Meeting details

VERTEX PHARMACEUTICALS INCORPORATED



Proposal 1.
Election of JOSHUA BOGER as director

Caisse vote:
For

Applicable policy or principle:
PR_05_01


Proposal 1.
Election of TERRENCE C. KEARNEY as director

Caisse vote:
For

Applicable policy or principle:
PR_05_01


Proposal 1.
Election of YUCHUN LEE as director

Caisse vote:
For

Applicable policy or principle:
PR_05_01


Proposal 1.
Election of ELAINE S. ULLIAN as director

Caisse vote:
Withold

Applicable policy or principle:
PR_05_01


Proposal 2.
RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2016.

Caisse vote:
For

Applicable policy or principle:
PR_06


Proposal 3.
ADVISORY VOTE ON OUR NAMED EXECUTIVE OFFICER COMPENSATION.

Caisse vote:
Against

Applicable policy or principle:
PR_07_06


Proposal 4.
SHAREHOLDER PROPOSAL, IF PROPERLY PRESENTED AT THE MEETING, REQUESTING THAT WE TAKE NECESSARY STEPS TO DECLASSIFY OUR BOARD OF DIRECTORS.

Caisse vote:
For

Applicable policy or principle:
PR_05_04


Proposal 5.
SHAREHOLDER PROPOSAL, IF PROPERLY PRESENTED AT THE MEETING, REQUESTING THAT WE ADOPT A POLICY LIMITING ACCELERATION OF EQUITY AWARDS TO SENIOR EXECUTIVES UPON A CHANGE OF CONTROL.

Caisse vote:
Against

Applicable policy or principle:
PR_12


Proposal 6.
SHAREHOLDER PROPOSAL, IF PROPERLY PRESENTED AT THE MEETING, REQUESTING THAT WE ADOPT A POLICY REQUIRING THAT SENIOR EXECUTIVES RETAIN A PERCENTAGE OF THEIR EQUITY AWARDS.

Caisse vote:
Against

Applicable policy or principle:
PR_07_04


Proposal 7.
SHAREHOLDER PROPOSAL, IF PROPERLY PRESENTED AT THE MEETING, REQUESTING A REPORT ASSESSING THE FEASIBILITY OF INTEGRATING SUSTAINABILITY INTO PERFORMANCE MEASURES FOR SENIOR EXECUTIVE COMPENSATION.

Caisse vote:
Against

Applicable policy or principle:
PR_12

See all shareholders' meetings for this company